"The health and safety of our patients, visitors, employees, and our communities remain a top priority at NewYork-Presbyterian. In response to the evolving COVID-19 outbreak and in line with our revised General Visitation Guidelines, we are keeping select entrances open at each Hospital throughout the enterprise. All other entrances will be closed and inaccessible to patients, visitors, and staff. The following entrances will remain open for patients, visitors, and employees: Main Entrance"

During the past decade, New York-Presbyterian Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York-Presbyterian Hospital" #1 collaborator was "Brain & Behavior Research Foundation" with 1 trials as a collaborator, "Forest Laboratories" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator, "Nathan Kline Institute for Psychiatric Research" with 1 trials as a collaborator and "National Center for Advancing Translational Sciences (NCATS)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "New York-Presbyterian Hospital" are "Schizophrenia" (3 trials), "Depression" (2 trials), "Schizoaffective Disorder" (2 trials), "Behavior Problems" (1 trials) and "Cognitive Deficits" (1 trials). Many other conditions were trialed in "New York-Presbyterian Hospital" in a lesser frequency.

Most popular intervention types in "New York-Presbyterian Hospital" are "Behavioral" (5 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Attention Bias Modification Computer Task" (1 trials), "CRT+ Social Cognition Training" (1 trials), "Cognitive Remediation (CRT)" (1 trials), "Contour Integration Training" (1 trials) and "Individual Psychotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York-Presbyterian Hospital" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "New York-Presbyterian Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in New York-Presbyterian Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in New York-Presbyterian Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".